Table 4 Correlations of renal colic-like pain symptoms and comorbidities.

From: Prevalence, correlates, and treatment behaviors for urolithiasis and renal colic-like pain symptoms at the population level in Poland

Parameter

Group

Renal colic-like pain symptoms

p

No

Yes

Hypertension

No (N = 6835)

4054 (59.31%)

2781 (40.69%)

p < 0.001 *

Yes (N = 3194)

1658 (51.91%)

1536 (48.09%)

 

Heart failure

No (N = 9279)

5392 (58.11%)

3887 (41.89%)

p < 0.001 *

Yes (N = 750)

320 (42.67%)

430 (57.33%)

 

Diabetes

No (N = 8970)

5216 (58.15%)

3754 (41.85%)

p < 0.001 *

Yes (N = 1059)

496 (46.84%)

563 (53.16%)

 

Gout

No (N = 9420)

5473 (58.10%)

3947 (41.90%)

p < 0.001 *

Yes (N = 609)

239 (39.24%)

370 (60.76%)

 

Liver disease

No (N = 9388)

5492 (58.50%)

3896 (41.50%)

p < 0.001 *

Yes (N = 641)

220 (34.32%)

421 (65.68%)

 

Gastrointestinal disease

No (N = 9534)

5542 (58.13%)

3992 (41.87%)

p < 0.001 *

Yes (N = 495)

170 (34.34%)

325 (65.66%)

 

Chronic kidney disease

No (N = 9683)

5640 (58.25%)

4043 (41.75%)

p < 0.001 *

Yes (N = 346)

72 (20.81%)

274 (79.19%)

 

Hyperparathyroidism

No (N = 9585)

5530 (57.69%)

4055 (42.31%)

p < 0.001 *

Yes (N = 444)

182 (40.99%)

262 (59.01%)

 

Overweight/obesity

No (N = 6804)

4028 (59.20%)

2776 (40.80%)

p < 0.001 *

Yes (N = 3225)

1684 (52.22%)

1541 (47.78%)

 

Polycystic kidney disease

No (N = 9779)

5642 (57.70%)

4137 (42.30%)

p < 0.001 *

Yes (N = 250)

70 (28.00%)

180 (72.00%)

 

Surgery of intestines

No (N = 9695)

5579 (57.55%)

4116 (42.45%)

p < 0.001 *

Yes (N = 334)

133 (39.82%)

201 (60.18%)

 

Sarcoidosis

No (N = 9884)

5671 (57.38%)

4213 (42.62%)

p < 0.001 *

Yes (N = 145)

41 (28.28%)

104 (71.72%)

 

Spinal cord injury

No (N = 9665)

5607 (58.01%)

4058 (41.99%)

p < 0.001 *

Yes (N = 364)

105 (28.85%)

259 (71.15%)

 

Multiple sclerosis

No (N = 9896)

5667 (57.27%)

4229 (42.73%)

p < 0.001 *

Yes (N = 133)

45 (33.83%)

88 (66.17%)

 

Cancer (any)

No (N = 9424)

5415 (57.46%)

4009 (42.54%)

p < 0.001 *

Yes (N = 605)

297 (49.09%)

308 (50.91%)

 

Hematological malignancies

No (N = 9905)

5670 (57.24%)

4235 (42.76%)

p < 0.001 *

Yes (N = 124)

42 (33.87%)

82 (66.13%)

 

Urological malignancies

No (N = 9789)

5608 (57.29%)

4181 (42.71%)

p < 0.001 *

Yes (N = 240)

104 (43.33%)

136 (56.67%)

 

Benign prostatic enlargement

No (N = 9243)

5305 (57.39%)

3938 (42.61%)

p = 0.003 *

Yes (N = 786)

407 (51.78%)

379 (48.22%)

 

Recurrent urinary tract infections

No (N = 8996)

5384 (59.85%)

3612 (40.15%)

p < 0.001 *

Yes (N = 1033)

328 (31.75%)

705 (68.25%)

 

Neurogenic lower urinary tract dysfunction

(neurogenic bladder)

No (N = 9785)

5628 (57.52%)

4157 (42.48%)

p < 0.001 *

Yes (N = 244)

84 (34.43%)

160 (65.57%)

 

Other urological diseases

No (N = 9652)

5619 (58.22%)

4033 (41.78%)

p < 0.001 *

Yes (N = 377)

93 (24.67%)

284 (75.33%)

 
  1. p—chi-square test or Fisher’s exact test.
  2. *Statistically significant difference (p < 0.05).